Table 1:
characteristics of the cohort, overall and based on outcome during acute course treatment. “RUL survivors” are those patients who received twelve RUL-BP treatments. “RUL censored” patients discontinued ECT prior to the twelfth treatment, but had all treatments using RUL-BP stimuli. “RUL dropouts” are the patients who transitioned from RUL-BP ECT to bilateral treatments during the acute course.
| All patients | RUL “survivors” | RUL “censored” | RUL “dropouts” | |
|---|---|---|---|---|
| N | 1383 | 298 | 567 | 518 |
| Sex = male (%) | 588 (42.5) | 124 (41.6) | 235 (41.4) | 229 (44.2) |
| Age (yrs; mean (SD)) | 49.4 (16.9) | 51.2 (17.0) | 49.8 (17.2) | 47.8 (16.3) |
| # of treatments (mean (SD)) | 9.4 (3.1) | 12 (0) | 6.7 (2.7) | 10.8 (1.9) |
| # of RUL treatments (mean (SD)) | 7.6 (3.3) | 12 (0) | 6.7 (2.7) | 6.0 (2.5) |
| Treatment #1 | Treatment #12 | Last before censoring | Last before dropout | |
| Dose (mC; mean (SD)) | 75.0 (38.4) | 406.8 (140.4) | 329.8 (151.9) | 371.1 (153.5) |
| Dose (mC; median) | 80 | 403.2 | 288 | 403.2 |
| Major depressive disorder (%) | 1008 (72.9) | 227 (76.2) | 412 (72.7) | 369 (71.2) |
| Bipolar disorder (%) | 211 (15.3) | 42 (14.1) | 75 (13.2) | 94 (18.1) |
| Other (%) | 70 (5.1) | 18 (6.0) | 25 (4.4) | 27 (5.2) |
| Missing (%) | 94 (6.8) | 11 (3.7) | 55 (9.7) | 28 (5.4) |